Galectins are a family of non-
integrin beta-galactosidase-binding
lectins. Altered expression of
galectins has been associated with neoplastic transformation and progression in several human
tumors. In this study, we examined the distribution patterns of
galectin-1 and
galectin-3 in normal (n=45), benign (n=16), and malignant (n=49) salivary gland specimens using immunohistochemistry to determine their diagnostic and/or
biological implications in salivary gland
tumorigenesis. In normal salivary glands,
galectin-3 expression was limited to ductal cells, and
galectin-1 was usually faintly detected in ductal cells and strongly positive in myoepithelial cells. In benign
tumors,
galectin-3 maintained the ductal localization, but
galectin-1 showed variable expression in ductal and myoepithelial cells. In malignant
tumors, most of the polymorphous low-grade
adenocarcinomas and
carcinoma ex-
pleomorphic adenomas expressed both
galectins, whereas adenoid cystic and
acinic cell carcinomas showed dramatically reduced
galectin-3 expression and heterogeneous galactin-1 staining. Our data demonstrated altered localization and expression of
galectin-3, and to lesser extent,
galectin-1 in salivary gland
carcinomas. These findings may assist in the differential diagnosis of some salivary gland
malignancies, especially when using small and limited fine-needle aspiration materials.